Placebos and Clinical Trials

Email a Friend

Beryl Lieff Benderly discusses the potential dangers of relying on double-blind clinical trials, which she sees as damaging the chances for patients in dire need of getting treatments. She also talks about why she thinks too many researchers are looking at what placebos aren't doing, as opposed to what they are. Her latest article, "Head Games," is in the current issue of Miller-McCune.